Yong Tao

Prof. Yong Tao


Biography

My research investigates the intersection of epigenetics, aging, and cancer, with a focus on how aberrant epigenetic modifications control cell fate. A central theme of our lab is that aging-like epigenetic alterations create a permissive state for tumorigenesis. Our work aims to elucidate this process and find ways to intervene. Our research activities are structured around three core areas: Identifying Driver Lesions: We use organoid models and multi-omics to discover and functionally validate key epigenetic changes and their target genes that drive both aging and cancer initiation. Dissecting Driving Mechanisms: We explore the upstream causes, such as DNA damage and metabolic stress, that lead to the accumulation of these epigenetic errors over time. Therapeutic Reprogramming: We develop and utilize advanced epigenome editing technologies to correct pathological epigenetic states, with the ultimate goal of reprogramming cell fate for therapeutic benefit in cancer/aging.

Affiliations

No affiliation has been shared yet.

Honors and Awards

No honors or awards have been shared yet.

Experience

Senior Scientist or Principal Investigator

Yunnan University, Kunming, China

01 Mar 2022 - present

Post Doctoral Researcher

Fred Hutchinson Cancer Center, Seattle, USA

01 Jun 2019 - 01 Mar 2022

Post Doctoral Researcher

Johns Hopkins Medicine, Baltimore, USA

01 Dec 2014 - 01 Jun 2019

Research or Laboratory Scientist

Beijing Institute of Genomics, Beijing, China

01 Jun 2009 - 01 Dec 2014